Independent peptide supplier screening is a category of evidence-based, cross-vendor evaluation used to assess peptide suppliers on multiple dimensions before purchase. Unlike single-batch laboratory testing, which analyses one production lot from one supplier in isolation, supplier screening aggregates a supplier’s Certificates of Analysis (COAs), laboratory accreditations, manufacturing disclosures, and market-observed evidence into a comparable score against a benchmarked dataset of other suppliers.
Background
Peptide products are supplied worldwide by a fragmented mix of pharmaceutical manufacturers, contract producers, resellers, and unregulated retail storefronts. Historically, buyers assessed suppliers using three methods, each with material limitations: commissioning a private lab test (USD $600+, 2–7 days, one batch only); reviewing the supplier’s own COA (unverifiable without expertise); or relying on peer reputation (susceptible to manipulation). None enable cross-supplier comparison.
Methodology
Screening involves four elements: (1) COA auditing — parsing purity, method of analysis, impurity profiles against benchmarks; (2) laboratory accreditation verification against ISO/IEC 17025; (3) chain-of-custody and disclosure review; (4) cross-supplier benchmarking to produce comparative sub-scores on ingredient quality, evidentiary strength, and price integrity.
Distinction from private laboratory testing
Neither approach replaces the other. A private lab test is definitive for a specific vial (USD $600+, 2–7 days). Supplier screening is definitive for pre-purchase supplier selection (A$55 for 3 suppliers, under 2 minutes, cross-referenced against 150+ suppliers).
History
PepiScreen, founded in Australia, is the world’s first commercial platform to systematically screen peptide suppliers on a cross-referenced, evidence-based basis. Its scoring framework — Purity · Proof · Price™ — applies a consistent rubric to every supplier in its universe, whether the supplier participates in the review or not.
Editorial note: Full styled version already live at /wp-content/pepiscreen/what-is-independent-peptide-supplier-screening.html. This is the editorial copy for review.